Carmell Therapeutics' Series A - IV Round

Carmell Therapeutics raised a round of funding on December 30, 2014. Investors include Lehigh Valley Angel Investors.

Carmell Therapeutics is developing biologically-active medical devices manufactured from blood plasma with growth and regenerative factors designed by nature in the right proportions to heal tissues. …

Articles about Carmell Therapeutics' Series A - IV Round: